Kurul Şerife, Reijnierse Joyce J, Koppens Hugo J, Onland Wes, Simons Sinno H P, Reiss Irwin K M, Taal H Rob, Visser Douwe H
Department of Pediatrics, Division Neonatology, Erasmus MC Sophia, Rotterdam, The Netherlands.
Department of Pediatrics, Division Neonatology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands.
BMJ Paediatr Open. 2024 Dec 29;8(1):e002884. doi: 10.1136/bmjpo-2024-002884.
The neonatal Sequential Organ Failure Assessment (nSOFA) score is an organ dysfunction score developed for predicting mortality risk in preterm neonates with proven late-onset neonatal sepsis (LONS) and necrotising enterocolitis. However, the utility of the nSOFA score in determining the risk of retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD) or mortality in patients with suspected LONS is unknown.
We performed a dual-centre retrospective cohort study of preterm (gestational age <32 weeks) neonates suspected of LONS, from 2016 to 2020 at two neonatal intensive care units. The nSOFA scores (range 0-15) were calculated for each suspected LONS episode at various time points around the sepsis evaluation. A nSOFA burden score was calculated, by counting each time point the nSOFA score was ≥4 during all sepsis episodes (in the time period -6 to 48 hours). The association with 10-day sepsis-related mortality and severe ROP and BPD was assessed.
A total of 1157 episodes of suspected LONS in 706 neonates occurred. The nSOFA was significantly associated with 10-day mortality at various time points. The nSOFA score 6 hours after drawing a blood culture (T6) was associated with 10-day sepsis-related mortality (adjusted OR (aOR) 1.31; 95% CI (1.22 to 1.40; p<0.001)), in a model corrected for gestational age, sex, age at evaluation and gestational age-adjusted birth weight. The nSOFA burden scores were positively associated with the risk for ROP (aOR 1.24; 95% CI 1.09 to 1.41; p=0.001) and BPD (aOR 1.30; 95% CI 1.13 to 1.50; p<0.001).
Our findings show that the nSOFA score in preterm neonates suspected of LONS is associated with subsequent mortality, ROP and BPD. Incorporating nSOFA scores may help to identify sepsis survivors at the highest risk of adverse outcomes, who may require more intensive monitoring and adapted therapy.
新生儿序贯器官衰竭评估(nSOFA)评分是一种器官功能障碍评分,用于预测确诊为晚发性新生儿败血症(LONS)和坏死性小肠结肠炎的早产儿的死亡风险。然而,nSOFA评分在确定疑似LONS患者发生早产儿视网膜病变(ROP)、支气管肺发育不良(BPD)或死亡风险方面的效用尚不清楚。
我们对2016年至2020年期间在两个新生儿重症监护病房的疑似LONS的早产儿(胎龄<32周)进行了一项双中心回顾性队列研究。在败血症评估前后的不同时间点,为每个疑似LONS发作计算nSOFA评分(范围0-15)。通过计算所有败血症发作期间(-6至48小时时间段内)nSOFA评分≥4的每个时间点,得出nSOFA负担评分。评估其与10天败血症相关死亡率、重度ROP和BPD的关联。
706例新生儿共发生1157次疑似LONS发作。nSOFA在不同时间点均与10天死亡率显著相关。在根据胎龄、性别、评估时年龄和胎龄校正出生体重进行校正的模型中,采血培养后6小时(T6)的nSOFA评分与10天败血症相关死亡率相关(校正后比值比(aOR)1.31;95%置信区间(CI)(1.22至1.40;p<0.001))。nSOFA负担评分与ROP风险(aOR 1.24;95%CI 1.09至1.41;p=0.001)和BPD风险(aOR 1.30;95%CI 1.13至1.50;p<0.001)呈正相关。
我们的研究结果表明,疑似LONS的早产儿的nSOFA评分与随后的死亡率、ROP和BPD相关。纳入nSOFA评分可能有助于识别出不良结局风险最高的败血症幸存者,这些幸存者可能需要更密切地监测和调整治疗。